1-(3-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid, 1g

Methyl 2-(1H-indol-3-yl)-2-oxoacetate, 95.0%, 10g

5-methyl-2-phenyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-amine, 95.0%, 250mg

2-Chloro-5-methylisonicotinic acid, 95%, 10g

Phenyl-pyridin-4-ylmethyl-amine, 1g

(2s)-3-Amino-2-methylpropan-1-ol, 97%, 100mg

3-Cyano-5-nitro-benzoic acid methyl ester, 98.0%, 25g

4-Bromophenoxy(t-butyl)dimethylsilane, 95%, 5g

Methyl 2-aminooxazole-5-carboxylate, 97.0%, 25g

(3-methyl-2-oxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid, 95.0%, 10g

1H-indazol-5-ol, 98%, 5g

5,6,7,8-Tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine, 98%, 500mg

valerenic acid, with analyt. Documents, 100 mg, glass packaging